Pathologic Features of Anti-Ku Myositis

Area of Science:

• Rheumatology
• Neurology
• Immunology
• Pathology

Background:

• Anti-Ku antibodies are associated with myositis, but their specific pathological characteristics remain poorly understood.
• Distinguishing anti-Ku myositis from other forms of immune-mediated necrotizing myopathy (IMNM) is crucial for accurate diagnosis and treatment.

Purpose of the Study:

• To elucidate the pathological features of anti-Ku antibody-positive myositis.
• To compare these features with IMNM associated with anti-signal recognition particle (anti-SRP) and anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibodies.
• To investigate potential associations with human leukocyte antigen (HLA) subtypes.

Main Methods:

• Retrospective analysis of muscle biopsy samples from Japanese and German cohorts diagnosed with anti-Ku myositis.
• Histological evaluation of muscle tissue, including assessment of necrosis, regeneration, MHC class II expression, and inflammatory cell infiltration.
• HLA phenotyping of patients with anti-Ku myositis.

Main Results:

• Anti-Ku myositis samples exhibited features common to IMNM but showed significantly higher expression of MHC class II and perivascular inflammatory cell clusters compared to anti-SRP/HMGCR IMNM.
• Biopsies of anti-Ku myositis could be classified into two subgroups based on necrosis and regeneration extent.
• Preliminary HLA associations were observed, suggesting potential differences between subgroups, though not statistically significant after correction.

Conclusions:

• Anti-Ku myositis can be differentiated from anti-SRP/HMGCR IMNM by distinct pathological markers, including MHC class II expression and perivascular inflammation.
• The findings suggest that anti-Ku myositis may comprise distinct subsets characterized by specific myopathological features and potential HLA associations.